Three things to consider when choosing a SIMM™ margin provider
Samuel Hyman, Head of Americas, Cassini Systems
If you trade bilateral OTC derivatives then you probably know by now that the Uncleared Margin Rules (UMR)...
CurveGlobal saw 194% volume rise YoY in February
By Pia Hecher.
CurveGlobal has claimed a record start to 2019, with monthly average trading up 194% in February over the same month in 2017....
China lays path to greater liquidity
Better risk and liquidity management is on the cards for the buy side as repo and derivatives are promoted by authorities and market infrastructure...
Larger dealers to benefit from bond electronification
By Vineet Naik.
Despite market volatility and regulatory pressures, there is stability at the top of the global fixed income market, reports analyst firm Greenwich...
Tabb: Derivatives boosting access to liquidity into 2019
By Pia Hecher.
Analyst firm TABB Group reports the number of market participants using corporate bond index futures and bond index total return swaps (TRSs)...
Developing liquid, sustainable markets in SOFR and SONIA
In conversation with Mark Rogerson, executive director, head of interest rate products, EMEA, CME Group
Momentum is gathering in the development of alternative reference rates...
Derivatives : Migrating benchmarks : Dan Barnes
LIBOR: WHEN TO JUMP ON THE SOFR
The transition from the London Interbank Offered Rate (LIBOR) to overnight indexed swap rates is moving, but when...
Derivatives : Brexit : Fred Maple
The impact of Brexit on European versus US derivatives trading.
Could the aftershock of Brexit land a win for the US? Fred Maple reports.
Many of...
Trading Technologies streamlines AI surveillance for fixed income and futures
By Pia Hecher.
Trading Technologies (TT), the producer of trading software platforms for automated buying and selling of futures, options and cryptocurrencies, has integrated its...
Derivatives : Exchange-traded products : Joel Clark
Why listed derivatives struggle to address risk
Some traders have been critical of listed products designed to replicate OTC derivatives, but exchanges are working hard...
